Cue Biopharma exec gets 13.6K shares, sells 5.6K
Cue Biopharma, Inc. (CUE) officer Michael Vincent Meluzio reported equity compensation activity and related tax sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cue Biopharma, Inc. (CUE) officer Michael Vincent Meluzio reported equity compensation activity and related tax sales. He exercised performance stock units, receiving 13,647 shares of Common Stock, and sold 5,628 shares on August 13, 2026 in block trades used to cover tax withholding obligations through a non-discretionary sell-to-cover arrangement. The exercised award represents one-third of a PSU grant tied to stock-price targets, with the remaining two-thirds eligible to settle only if higher share-price hurdles are achieved within a specified performance period.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
5 txns
Insider
Meluzio Michael Vincent
Role
VP, Prin. Accounting Officer
Sold
5,628 shs ($169K)
Approx. gross sale proceeds
$169K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Stock F4 | 13,647 | $0.00 | $0.00 |
| Exercise | Common Stock | 13,647 | $0.00 | $0.00 |
| Sale | Common Stock F1, F2 | 1,519 | $29.37 | $45K |
| Sale | Common Stock F1, F3 | 4,106 | $30.35 | $125K |
| Sale | Common Stock F1 | 3 | $31.13 | $93.39 |
Holdings After Transaction:
Common Stock — 27,295 contracts (Direct);
Common Stock — 48,961 shares (Direct)
Footnotes (4)
- F1. The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.
- F2. The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $28.97 to $29.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.
- F3. The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $29.99 to $30.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.
- F4. The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.
Key Figures
PSUs Exercised into Shares: 13,647 shares
Total Shares Sold: 5,628 shares
Sale Price Block 1: $29.37 per share
+5 more
8 metrics
PSUs Exercised into Shares
13,647 shares
Performance stock units settled into Common Stock on August 13, 2026
Total Shares Sold
5,628 shares
Shares sold on August 13, 2026 to cover tax withholding via sell-to-cover
Sale Price Block 1
$29.37 per share
1,519 shares sold at a weighted average price, within $28.97–$29.96 range
Sale Price Block 2
$30.35 per share
4,106 shares sold at a weighted average price, within $29.99–$30.97 range
Sale Price Block 3
$31.13 per share
3 shares sold at stated per-share price
First PSU Price Hurdle
$33.00 per share
First of three stock-price targets for PSU vesting, five consecutive trading days
Second PSU Price Hurdle
$38.50 per share
Second stock-price target for remaining PSU tranches
Third PSU Price Hurdle
$44.00 per share
Third stock-price target for remaining PSU tranches
Key Terms
performance stock units, restricted stock units, sell-to-cover, weighted average price, +1 more
5 terms
performance stock units financial
"The performance stock units ("PSU") were awarded subject to certain stock-price"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
restricted stock units financial
"in connection with the vesting and settlement of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell-to-cover financial
"to be funded by a "sell-to-cover" transaction and do not represent"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
weighted average price financial
"The price reported in this line item is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
block trades financial
"These shares were sold as part of block trades for multiple security holders"
A block trade is a single, large buy or sell of shares or bonds arranged privately between big traders rather than piecemeal on the public market. Think of it like buying a whole shipment at once instead of many small shopping trips; it lets large holders move big positions with less immediate disruption but can signal strong buying or selling pressure and cause price swings once the trade is known, so investors watch block trades for clues about market sentiment and liquidity.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did CUE executive Michael Vincent Meluzio report on this Form 4?
Michael Vincent Meluzio reported exercising 13,647 performance stock units into Common Stock and selling 5,628 shares on August 13, 2026. The sales were executed as block trades and used to cover tax withholding obligations via a sell-to-cover arrangement, not as discretionary open-market sales.
What are the performance conditions on Meluzio’s CUE performance stock units (PSUs)?
Meluzio’s PSUs vest in three tranches based on stock-price hurdles of $33.00, $38.50, and $44.00, each requiring a closing price at or above the target for five consecutive trading days. Any unsatisfied targets by 24 months from grant cause those PSUs to be forfeited.
How much of Meluzio’s Cue Biopharma PSU award vested in August 2026?
On August 13, 2026, one-third of Meluzio’s performance stock unit award settled, delivering 13,647 shares of Common Stock. The remaining two-thirds will only settle if higher stock-price targets of $38.50 and $44.00 are achieved for five consecutive trading days within the performance window.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates